TriSalus Life Sciences, Inc.
TLSINasdaqCIK 1826667HealthcareFiscal year ends Dec 31
Reports and events: 142 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2220:14 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063031 |
| 2026-08-0620:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-054275 |
| 2026-08-0620:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-054264 |
| 2026-05-1420:03 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-035068 |
| 2026-05-1220:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-034100 |
| 2026-05-1220:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-034082 |
| 2026-04-2920:32 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-028425 |
| 2026-04-0713:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-023991 |
| 2026-03-3122:17 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001628280-26-022124 |
| 2026-03-0521:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-015163 |
| 2026-03-0521:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-015155 |
| 2026-02-2021:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-007598 |
| 2026-02-0913:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-006219 |
| 2026-01-1212:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-001743 |
| 2025-11-1321:14 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-052043 |
| 2025-11-1321:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-052008 |
| 2025-10-0120:28 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-043440 |
| 2025-08-2920:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001826667-25-000129 |
| 2025-08-1220:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001826667-25-000117 |
| 2025-08-1220:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001826667-25-000115 |
| 2025-08-0411:33 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001826667-25-000108 |
| 2025-08-0121:16 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001826667-25-000106 |
| 2025-07-2421:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001826667-25-000103 |
| 2025-06-2321:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001826667-25-000077 |
| 2025-06-1621:07 ET | 8-K | 5.07 Shareholder vote results | 0001826667-25-000074 |
| 2025-05-3020:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001826667-25-000071 |
| 2025-05-3020:00 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001826667-25-000070 |
| 2025-05-1511:54 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001826667-25-000051 |
| 2025-05-1511:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001826667-25-000049 |
| 2025-05-0220:17 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-25-011783 |
| 2025-04-3021:21 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001826667-25-000040 |
| 2025-04-3012:05 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-041862 |
| 2025-04-2312:57 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001826667-25-000036 |
| 2025-04-1720:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001826667-25-000033 |
| 2025-04-1521:04 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001826667-25-000030 |
| 2025-03-2711:56 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001826667-25-000024 |
| 2025-02-2521:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001826667-25-000021 |
| 2025-02-1922:31 ET | 8-K | 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001826667-25-000018 |
| 2025-02-0316:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001826667-25-000014 |
| 2025-01-3121:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001826667-25-000011 |
| 2025-01-2313:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001826667-25-000007 |
| 2025-01-0821:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-002023 |
| 2024-12-1921:12 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-24-029847 |
| 2024-12-1921:12 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001415889-24-029845 |
| 2024-11-1413:34 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001826667-24-000051 |
| 2024-11-1413:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-118338 |
| 2024-11-0120:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-24-113486 |
| 2024-08-1512:55 ET | 8-K | 2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-089936 |
| 2024-08-1420:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001826667-24-000039 |
| 2024-07-1920:48 ET | DEF 14A | Proxy statementPeriod 2024-07-10 | 0001826667-24-000034 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.